SOR-C13 shows promise in different cancers

SOR-C13 shows promise in different cancers

Cancer-News

5 months
156 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
Report 0 0
Category:
Description:
Jack Stewart, CSO of Soricimed Biopharma explains SOR-C13 potentially shows promise in ovarian,
metastatic prostate and pancreatic cancer.
Up Next Autoplay